StudyRareStudyRare

Nonimmune hydrops fetalis

Log in to star

Last updated Nov 9, 2026

Log in to add personal notes on this page.

Abnormal fluid in two or more fetal compartments: ascites, pleural effusion, pericardial effusion, or skin edema thicker than 5 mm. Polyhydramnios and a thick placenta often come with it. Hydrops is immune when maternal red cell antibodies destroy fetal red cells and nonimmune otherwise. Since anti-D immune globulin, about 90% of cases are nonimmune. Nonimmune hydrops is not a diagnosis. It is the end stage of many disorders, and perinatal mortality runs 50 to 90%.

Fluid collects when venous pressure rises (heart failure, anemia), lymph cannot drain, or plasma oncotic pressure falls. Once the antibody screen is negative, three questions narrow the list:

  1. When was it found? Aneuploidy explains about 80% of hydrops found at 17 weeks or earlier and about 30% found at 24 weeks or later.
  2. Is the fetus anemic? A raised middle cerebral artery peak systolic velocity (MCA PSV) points to alpha thalassemia, parvovirus B19, or fetomaternal hemorrhage.
  3. Who are the parents? Southeast Asian, Filipino, or Mediterranean ancestry with microcytosis raises Hb Bart's. Consanguinity or a previous hydropic pregnancy raises recessive disease.

Shares are from a systematic review of 5,437 cases, 18% of which stayed unexplained.

Cardiovascular (about 22%)

  • Structural heart disease: hypoplastic left or right heart, atrioventricular canal defect, Ebstein anomaly. See congenital heart disease.
  • Arrhythmias: supraventricular tachycardia and atrial flutter most often; heart block.
  • Cardiac rhabdomyomas: tuberous sclerosis complex.

Chromosomal (about 13%)

Hematologic (about 10%)

  • Alpha thalassemia, Hb Bart's hydrops fetalis: all four alpha-globin genes deleted (--/--, HBA1 and HBA2). Each parent usually carries two deletions in cis (--/αα), such as --SEA, --FIL, or --MED. Hb Bart's causes 28 to 55% of nonimmune hydrops in Southeast Asian populations. Two trans carriers (-α/-α) cannot conceive a Bart's pregnancy.
  • Fetomaternal hemorrhage.
  • Inherited red cell disorders: G6PD deficiency, pyruvate kinase deficiency, Diamond-Blackfan anemia.

Infection (about 7%)

  • Parvovirus B19, the most common infectious cause: it infects erythroid progenitors and stops red cell production, a transient aplastic anemia. Also cytomegalovirus (CMV), syphilis, and toxoplasmosis. See infectious teratogens.

Lymphatic dysplasia (about 6%) and RASopathies

  • Noonan syndrome and the other RASopathies (Costello, cardiofaciocutaneous): about one third of euploid nonimmune hydrops. Increased nuchal translucency, cystic hygroma, pleural effusion, polyhydramnios, pulmonary stenosis.
  • Other lymphatic disorders: lymphedema-distichiasis syndrome, Milroy disease, generalized lymphatic dysplasia.

Thoracic masses and twins (about 6% each)

  • Diaphragmatic hernia, congenital pulmonary airway malformation, pulmonary sequestration, chylothorax.
  • Twin-twin transfusion syndrome; acardiac twin.

Inborn errors of metabolism (1 to 5%)

Skeletal dysplasia and fetal akinesia

  • Cystic hygroma with hydrops before 20 weeks: aneuploidy, 45,X first.
  • Normal anatomy with an MCA PSV of 1.5 multiples of the median or more: fetal anemia from parvovirus, Hb Bart's, or fetomaternal hemorrhage.
  • Both parents microcytic with normal iron studies and Southeast Asian ancestry: Hb Bart's.
  • Euploid fetus with a normal microarray, earlier increased nuchal translucency, and pulmonary stenosis: RASopathy.
  • Ascites-first hydrops with an enlarged liver and spleen, recurrence, or consanguinity: lysosomal storage disease.
  1. Maternal blood type and indirect Coombs test, repeated even if an earlier screen was negative, to exclude immune hydrops.
  2. Detailed ultrasound with MCA PSV and a fetal echocardiogram for structure and rhythm.
  3. Maternal CBC and hemoglobin electrophoresis, with the other parent's red cell indices (MCV). Send HBA1/HBA2 deletion analysis when either parent is microcytic: a normal electrophoresis does not exclude alpha thalassemia trait, and only DNA testing separates cis from trans.
  4. Kleihauer-Betke stain or flow cytometry for fetomaternal hemorrhage, and serology for parvovirus B19, CMV, toxoplasmosis, and syphilis.
  5. Amniocentesis with chromosomal microarray, with or without karyotype, plus PCR for parvovirus, CMV, and toxoplasmosis when infection is possible.
  6. Exome or genome sequencing when the microarray is normal, or alongside it when the aneuploidy risk is low. A RASopathy, hydrops, or metabolic panel if sequencing is unavailable.
  7. Lysosomal enzyme assays on amniotic fluid or cultured amniocytes, or the genes on a panel or exome.
  8. If the pregnancy is lost: autopsy with placental pathology, skeletal X-rays, photographs, and a stored fibroblast line and DNA.
  • Mirror syndrome: the pregnant patient develops a form of preeclampsia, with edema that "mirrors" the hydropic fetus, in 8 to 38% of nonimmune hydrops pregnancies. Plan for delivery; expectant management is reserved for rare cases.
  • Arrangement, not count: Hb Bart's needs a cis deletion from each parent. Order deletion analysis before counseling a microcytic couple.
  • Anemic hydrops can be treated: intrauterine transfusion can carry a fetus through parvovirus aplastic anemia.
  • Store tissue while you can: for recurrent unexplained hydrops, a fibroblast line and frozen amniotic fluid keep a later diagnosis possible.